Introducing the Expanded Etoricoxib Product Range- We are thrilled to announce the launch of an expanded Etoricoxib product range, now available in combination with Paracetamol and Thiocolchicoside. These powerful combinations are designed to address a wider spectrum of pain and inflammation, providing healthcare providers with flexible options for managing both acute and chronic musculoskeletal conditions. Product Range Overview: 1. Etoricoxib Alone: o Available in multiple strengths (60 mg, 90 mg, and 120 mg), Etoricoxib alone targets various inflammatory conditions with the benefits of selective COX-2 inhibition, providing effective pain relief with reduced gastrointestinal side effects. 2. Etoricoxib + Paracetamol: o This combination brings together Etoricoxib’s anti-inflammatory action and Paracetamol’s pain-relieving and antipyretic effects. It’s ideal for managing moderate to severe pain, especially in conditions where enhanced pain relief is essential without additional muscle relaxation. o Indications: Acute musculoskeletal pain, arthritis flare-ups, dental pain, and post-surgical pain. 3. Etoricoxib + Thiocolchicoside: o Combining Etoricoxib with Thiocolchicoside, a muscle relaxant, this option is designed for conditions where pain and muscle spasms occur together. Thiocolchicoside provides muscle relaxation, making this combination particularly effective for patients experiencing muscle stiffness and spasms alongside inflammation. o Indications: Acute muscle spasms, back pain, cervical pain, postural pain, and post-surgical muscle pain. Key Benefits of the Etoricoxib Product Range: • Comprehensive Pain and Inflammation Management: Each combination serves a unique therapeutic purpose, allowing tailored treatment for specific patient needs. • Reduced Gastrointestinal Risks: As a COX-2 inhibitor, Etoricoxib reduces the risk of gastrointestinal side effects commonly seen with traditional NSAIDs. • Flexibility in Dosage and Application: Available in multiple combinations and strengths, our Etoricoxib range offers healthcare providers flexibility in selecting the most appropriate formulation for each patient. • Enhanced Patient Outcomes: With targeted therapy options, patients experience better pain relief, improved mobility, and faster recovery from musculoskeletal conditions. #SojusHealthcare, #PCDPharmaFranchise, #Antibiotics, #Nsaid’sPainkillers, #GynaecologicalProducts, #Expectorants, #NutritionalMultivitamins, #NutritionalMultiminerals, #ProtonPumpInhibitor, #(PPI), #NeurologyProducts, #MiscellaneousPharmaceuticalProducts, #Injectables, #CardiologyProducts, #DiabeticProducts, #Antibacterials, #Antidiarrhoeals, #Antifungals, #Antihistamines, #Gastroenterology, #HerbalProducts, #UrologyProducts, #ArthrologyProducts, #MuscleRelaxants, #Tablets, #Capsules, #Syrup, #Ointments, #Drops, #Inhalers, #Liquids, #Suppositories, #Antacids, #Anesthetics, #Glucocorticoids, #DermatologyProducts, #ACE inhibitors with calcium channel blocking agents, #AdrenalCorticalSteroids, #Allergenics, #AlphaBlockers, #AlternativeMedicines, #AnalgesicCombinations, #Anti-infectives, #AntianginalAgents, #AntiarrhythmicAgents